Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003

Alan P Johnson; Theresa L Lamagni; Martin Wale; Sue Cavendish; Louise Bishop; Neelam Alhaddad; Marina Warner; David M Livermore; Georgia Duckworth; Robert C George

doi:10.1016/j.ijantimicag.2004.10.017

Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003

Alan P Johnson, Theresa L Lamagni, Martin Wale, Sue Cavendish, Louise Bishop, Neelam Alhaddad, Marina Warner, David M Livermore, Georgia Duckworth, Robert C George

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.

Original language	English
Pages (from-to)	539-41
Number of pages	3
Journal	International Journal of Antimicrobial Agents
Volume	25
Issue number	6
DOIs	https://doi.org/10.1016/j.ijantimicag.2004.10.017
Publication status	Published - Jun 2005

Keywords

Anti-Bacterial Agents
Aza Compounds
Drug Resistance, Bacterial
England
Erythromycin
Humans
Inpatients
Microbial Sensitivity Tests
Penicillins
Quinolines
Streptococcus pneumoniae

Access to Document

10.1016/j.ijantimicag.2004.10.017

Cite this

Johnson, A. P., Lamagni, T. L., Wale, M., Cavendish, S., Bishop, L., Alhaddad, N., Warner, M., Livermore, D. M., Duckworth, G., & George, R. C. (2005). Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003. International Journal of Antimicrobial Agents, 25(6), 539-41. https://doi.org/10.1016/j.ijantimicag.2004.10.017

@article{9f6a1dae75d64c539442a3c415c19ed3,

title = "Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003",

abstract = "Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.",

keywords = "Anti-Bacterial Agents, Aza Compounds, Drug Resistance, Bacterial, England, Erythromycin, Humans, Inpatients, Microbial Sensitivity Tests, Penicillins, Quinolines, Streptococcus pneumoniae",

author = "Johnson, {Alan P} and Lamagni, {Theresa L} and Martin Wale and Sue Cavendish and Louise Bishop and Neelam Alhaddad and Marina Warner and Livermore, {David M} and Georgia Duckworth and George, {Robert C}",

year = "2005",

month = jun,

doi = "10.1016/j.ijantimicag.2004.10.017",

language = "English",

volume = "25",

pages = "539--41",

journal = "International Journal of Antimicrobial Agents",

issn = "0924-8579",

publisher = "Elsevier",

number = "6",

}

Johnson, AP, Lamagni, TL, Wale, M, Cavendish, S, Bishop, L, Alhaddad, N, Warner, M, Livermore, DM, Duckworth, G & George, RC 2005, 'Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003', International Journal of Antimicrobial Agents, vol. 25, no. 6, pp. 539-41. https://doi.org/10.1016/j.ijantimicag.2004.10.017

Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003. / Johnson, Alan P; Lamagni, Theresa L; Wale, Martin et al.

In: International Journal of Antimicrobial Agents, Vol. 25, No. 6, 06.2005, p. 539-41.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003

AU - Johnson, Alan P

AU - Lamagni, Theresa L

AU - Wale, Martin

AU - Cavendish, Sue

AU - Bishop, Louise

AU - Alhaddad, Neelam

AU - Warner, Marina

AU - Livermore, David M

AU - Duckworth, Georgia

AU - George, Robert C

PY - 2005/6

Y1 - 2005/6

N2 - Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.

AB - Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.

KW - Anti-Bacterial Agents

KW - Aza Compounds

KW - Drug Resistance, Bacterial

KW - England

KW - Erythromycin

KW - Humans

KW - Inpatients

KW - Microbial Sensitivity Tests

KW - Penicillins

KW - Quinolines

KW - Streptococcus pneumoniae

U2 - 10.1016/j.ijantimicag.2004.10.017

DO - 10.1016/j.ijantimicag.2004.10.017

M3 - Article

C2 - 15890501

VL - 25

SP - 539

EP - 541

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 6

ER -